In 2022, the International League Against Epilepsy (ILAE) classified PDE as a cause-specific epilepsy syndrome and named it pyridoxine dependent (ALDH7A1) – developmental and epileptic encephalopathies, PD-DDE (4). This evidence concerns the gene ALDH7A1 and epilepsy syndrome.